MedTrace Logo

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

NCT02130505 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2014-05-05

No results posted yet for this study

Summary

In this study, we will investigate both inflammatory systems in healthy volunteers and patients with T2DM on insulin therapy and hyperlipidemia (both familial hyperlipidemia (FH) and familial combined hyperlipidemia (FCH)) during an OGTT.

Conditions

Interventions

DIETARY_SUPPLEMENT

OGTT

Oral glucose tolerance test (OGTT) with 75 g of oral anhydrous glucose

Sponsors & Collaborators

  • Sint Franciscus Gasthuis

    lead OTHER

Principal Investigators

  • Manuel Castro Cabezas, MD, PhD · Sint Franciscus Gasthuis

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02130505 on ClinicalTrials.gov